Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001235472 | SCV001408159 | pathogenic | Charcot-Marie-Tooth disease type 2E | 2019-08-22 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with leucine at codon 8 of the NEFL protein (p.Pro8Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 19158810, 12566280). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 66689). This variant disrupts the p.Pro8 amino acid residue in NEFL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12566280, 17620486, 12393795). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Epithelial Biology; Institute of Medical Biology, |
RCV000057132 | SCV000088245 | not provided | not provided | no assertion provided | not provided |